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Abstract
Canine adipose-derived stem cells (cASCs) have great interest for cell-based therapies in Veterinary Medicine. 
As the behaviour of these cells in non-autologous recipients is not deeply characterized, it is mandatory to study them 
in new animal models previously to canine specie. In this work, cASCs were injected subcutaneously in mice and 
these cells were detected by immunohistochemistry using vimentin, CD44 and keratin. The local response evaluated 
by histology did not reveal signals of significant inflammatory reaction neither in the lymph nodes or other organs. 
This study showed the implantation of cASCs induced a scarce inflammatory response. Hsd:CD1 (ICR) mouse can 
be proposed as an animal model to study the in vivo behavior of the cASCs and to validate new cASCs-based 
approaches avoiding or reducing the use of dogs in research.
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Introduction
The use of Mesenchymal Stem Cells (MSCs) has been proposed for 
a wide number of Regenerative Medicine strategies, mainly due to their 
ability to self-renew and potential to differentiate towards different cell 
lineages. These cells have been initially isolated from the bone marrow 
[1] but, since then, it has been reported its existence in many other 
adult tissues, including the adipose tissue [2,3], placenta, amniotic fluid 
[4], umbilical cord blood [5] and periodontal ligament or other dental 
tissues [6,7].
Adipose-derived stem cells (ASCs) have shown remarkable 
properties with great potential to be used in Tissue Engineering and 
other cell-based therapies [8], regarding their ability to differentiate 
into several cellular lineages, easiness of harvesting with low morbidity 
and discomfort to the patient [8].
The canine adipose-derived stem cells (cASCs) have recently 
been reported in several studies in Regenerative Medicine with 
promising results. Concerning clinical studies, cASCs have been used 
in combination with scaffolds based on hydroxyapatite and chitosan 
(30:70 wt%) for the treatment of radius and ulna nonunion fracture 
in dog [9], or in the treatment of dogs with lameness associated with 
osteoarthritis of the coxofemoral [10] and humeroradial [11,12] joints. 
Although without effective clinical improvement, cASCs have also 
been tested in the treatment of canine atopic dermatitis [13].
At a preclinical stage, cASCs have been studied in canine models 
for the regeneration of intervertebral disc [14] or the inhibition of its 
degeneration [15], and for the regeneration of cranial bone defects by 
autologous [16] or allogenic [17] cASCs combined with coral scaffolds. 
Additionally, cASCs have also been assessed as cellular delivery system 
of interferon-β gene for cancer therapy using a mouse melanoma 
model [18].
Despite the increasing interest in this cell source, there is not 
enough information to enables to assess cASCs in smaller animal 
models. Cell-based therapies in dogs are quite promising in Veterinary 
Medicine, thus, prior to apply these strategies in dogs, it is mandatory 
to study the behavior of cells, for example cASCs, in animal models 
such as small laboratory mammals. The transplantation of stem cells 
in dogs, alone or as part of tissue-engineered constructs, could also be 
further translated (or be a model) to Regenerative Medicine in humans.
In this work, the cASCs were xenotransplanted in a mouse 
subcutaneous model without any specific induced disease. The 
implanted cells were immunodetected throughout the timeline of the 
experiment and the host response was evaluated. The obtained data 
contributed to the characterization of mice as model to assess cASCs 
before their application in veterinary clinical practice.
Materials and Methods
Preparation of the canine adipose-derived stem cells
Surgical harvesting of the canine adipose tissue: Subcutaneous 
abdominal adipose tissue was harvested from three adult healthy female 
dogs, between 1 to 3 years old, subjected to elective ovariohysterectomy 
at the Veterinary Hospital of University of Trás-os-Montes e Alto 
Douro with previous informed consent of the owners.
Dogs were sedated by an intramuscular administration of 0.2 mg/kg 
IM butorphanol tartrate (Torbugesic 1%; Fort Dodge, the Netherlands) 
and 30 µg/kg IM acepromazine maleate (Vetranquil; CEVA Sante 
Animal, France). Anaesthesia was achieved by an intravenous 
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administration of 0.25 mg/kg IV diazepam (Diazepam MG; Labesfal, 
Portugal), 4 mg/kg IV ketamine (Imalgene 1000; Merial, France) and 4 
mg/kg IV propofol (Lipuro 2%; Braun, Germany), and was maintained 
with 1% isoflurane (IsoFlo; Abbott Animal Health, USA) administered 
in oxygen through an endotracheal tube.
After being anesthetized, the dogs were placed in dorsal recumbence 
and it was made a careful tricothomy and asepsis of the ventral abdomen 
from the xiphoid to the pubis. Briefly, an incision was made just caudal 
to the umbilicus in the cranial third of the caudal abdomen through 
skin. Samples of adipose tissue were collected from the abdominal 
subcutaneous region, before the perform the ovariohysterectomy.
Finally, linea alba was closed with simple interrupted suture using 
polyglyconate (Monosyn; BBraun, Portugal), the subcutaneous tissue 
with a simple continuous suture using the same material, and the skin 
with a simple interrupted pattern using silk (Silkan, BBraun, Portugal).
Isolation and expansion of the canine ASCs: The subcutaneous 
adipose tissue samples were processed within 12 hrs upon harvesting, 
and the canine adipose-derived stem cells (cASCs) were isolated 
by an enzymatic digestion method, as described previously [2]. 
Briefly, adipose tissue samples were washed with PBS containing 
10% antibiotics/antimycotic and minced into small fragments. The 
fragments were digested with a solution of 0.1% collagenase type IA 
(Sigma Aldrich, Germany) in PBS at 37°C under shacking at 200 rpm 
for 40 min. The digested tissue was filtered with a 100 μm nylon meshe 
and centrifuged at 1,250 rpm for 5 min at 20°C and the supernatant 
removed.
The obtained cells were resuspended and expanded in basal 
medium composed of Dulbecco Modified Eagle Medium (DMEM) 
(Sigma Aldrich, Germany) supplemented with 10% fetal bovine serum 
(FBS; Invitrogen, USA) and 1% antibiotic/antimicotic (amphotericin 
B/streptomycin sulfate; Sigma, USA) up to passage 2 as reported before 
[2] in order to obtain the necessary number of cells to use in this study.
Preparation of the canine ASCs suspension: The cASCs were 
resuspended in phosphate buffer solution (PBS; Sigma Aldrich, 
Germany), obtaining a cellular suspension of 1×107 cells ml-1 to be 
subsequently 100 microliter injected in the mice.
From the same culture, a cellular suspension of 2×106 cASCs 
ml-1 was also obtained, washed with PBS and fixed in 4% phosphate-
buffered formalin for further cytology and immunostaining assays.
Mice: Thirty five immunocompetent 10 weeks old Hsd: CD1 
(ICR), outbred and SPF male mice (Harlan Laboratories, Spain) were 
used in this protocol. As the objective of the study was to evaluate the 
inflammatory reaction of mice against xenogenic transplanted cells, 
therefore the selected animal model had to be immunocompetent.
The housing care and experimental protocol was performed 
according to the national guidelines, after approval by the National 
Ethical Committee for Laboratory Animals and conducted in 
accordance with Portuguese legislation (Portaria 1005/92) and 
international standards on animal welfare as defined by the European 
Directive 2010/63/EU.
The animals were housed in groups of five individuals, fed ad 
libitum with maintenance diet for mice (4RF21/C diet, Mucedola, Italy) 
and autoclaved water, and bedded in corn cob (Scobis Due, Mucedola, 
Italy) with suitable environment enrichment and with a day/night cycle 
of 14/10 hrs.
Subcutaneous injection of the canine ASCs
Mice were placed in dorsal recumbence for subcutaneous injection 
in the abdominal right flank with 100 µl of suspension containing 
1×107 cells ml-1 by using a 1 ml syringe with a 26 G needle.
Euthanasia and explants collection
All animals were euthanized by an intravenous injection of sodium 
pentobarbital (Eutasil, CEVA, France). In order to the assess the effect 
of the injection on the skin and its histology of without the influence 
of the cASCs, a group of five animals injected with PBS with no cells 
were, considered the negative control for cASCs and euthanized at 12 
hrs. Throughout the following 28 days, the remaining six experimental 
groups (n=5) were sacrificed at 12 hrs, and 1, 3, 7, 21 and 28 days after 
injection.
The abdominal skin and adjacent muscle, around the site of 
injection, were collected with a safety margin of 1 cm, in order to assess 
the local response against the xenotransplanted cASCs.
The organs, namely, mesenteric and inguinal lymph nodes, liver, 
kidney, lung, heart, spleen, brain, and intestine were also collected, in 
order to evaluate the presence of cASCs at distance and also the host 
response against these cells. All samples were fixed in 4% phosphate-
buffered formalin (Inopat, Portugal) during 24 hrs.
Preparation of the canine ASCs’ cytoblocks
A cellular culture suspension of 2×106 cASCs ml-1 was fixed in 4% 
phosphate-buffered formalin and centrifuged in the Shandon CytoSpin 
3 centrifuge (Thermo Scientific, USA) to a cytoblock cassette.
Hematoxylin and eosin
Explants retrieved from mice and the cASCs’ cytoblock were 
processed in an automatic tissue processor Shandon Hypercenter XP 
(ThermoFisher Scientific, USA) and embedded in paraffin. Paraffin 
blocks were cut at 3 μm to silane-coated slides and stained by routine 
with hematoxylin and eosin (H&E) and mounting with Entellan 
(Merck, Germany).
Immunohistochemistry
Mouse monoclonal antibodies anti-human Vimentin, (clone V9, 
Leica Biosystems, UK) and anti-human Keratin (clone AE1/AE3, 
Dako, USA), and rat monoclonal anti-mouse CD44 (clone IM7, Santa 
Cruz Biotechnology, Germany) (Table 1) were used to perform indirect 
avidin-biotin immunohistochemistry (IHQ) technique in order to 
characterize the injected cASCs in the host tissue.
Antigen retrieval was performed in a water bath at 96ºC for 20 
min, in citrate buffer (pH=6). The slides were washed with PBS and 
Antibody Vimentin Keratin CD44
Type Monoclonal Monoclonal Monoclonal
Clone V9 AE1/AE3 IM7




Dilution 0.111111111 0.319444444 0.111111111
Antigen 
retriever
Sodium citrate, pH 6, 
90ºC, 20 min
Sodium citrate, pH 6, 
90ºC, 20 min  
Incubation Room temperature, 4 hrs Room temperature, 4 hrs 4ºC, overnight
Table 1: Antibodies used in this study.
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lymph nodes presented normal morphology with brown pigment 
(hemosiderin) in some cases.
Immunohistochemistry
The skin samples were submitted to IHC in order to identify if the 
cellular agglomerates match with cASCs according to their phenotype. 
endogenous peroxidase was blocked with 3% hydrogen peroxide 
(Sigma, Germany) at room temperature for 30 min.
RTU Vectastain Universal Elite ABC Kit (Vector PK-7200, UK) 
in combination with the Mouse-on-Mouse (MOM) Basic Kit (Vector 
BMK-2202, UK) was used for antibody incubation, according to the 
instructions of the manufacturers, in order to reduce the background 
and antibody cross reactivity.
The mouse-on-mouse kit aimed to block the endogenous 
mouse’s immunoglobulins was essential to avoid the detection of the 
studied antibodies in the host tissue, ensuring that only the canine 
xenotransplanted cells were identified through histological stainings of 
the explants. Briefly, non-specific binding of primary antibodies was 
blocked using a horse serum for 5 min, and the mice’s immunoglobulins 
blocked for 1 hour. Then, after an overnight incubation with the 
primary antibody, at 4ºC in a humidified atmosphere, tissue sections 
were incubated with biotinylated antibody, followed by incubation 
with streptavidin-peroxidase.
After washing with PBS, antibody detection was revealed using 
the peroxidase substrate kit DAB (Vector SK-4100, UK). Slides 
were washed in water for 5 min and then counterstained with Gill’s 
hematoxylin (Sigma, Germany).
The sections of the cASCs’ cytoblock were submitted to the same 
procedure and used as positive control of the immunohistochemistry 
analysis. Finally, the sections were observed under a light microscope 
(E600 Nikon Instruments, UK) and the images were obtained using the 
digital camera Nikon DXM200. The cells were interpreted as positive 
when revealed brown cytoplasm.
Results
The subcutaneous injections of cells promoted the formation of 
small papules immediately after the injection of the cellular suspension. 
A few minutes upon implantation, it was observed the regularization of 
the skin and no signs of local inflammation were detected after that. In 
each timepoint, all the animals revealed good body condition and also 
no clinical signs of inflammation were noticed.
During the samples collection for histological processing, it was 
observed a certain degree of local skin swelling in first experimental 
group corresponding to 12 hrs post-transplantation.
Histology
All organs and skin from all animals were evaluated hematoxylin 
and eosin-stained slides. The organs did not show any significant 
histology disorder. Histological analysis of the local of injection in the 
abdominal skin (Figures 1 and 2) revealed normal skin architecture in 
the negative control group (Figure 1), comprising the animals where 
no cells were transplanted. On other groups, at 12 hrs, one and seven 
days after cells inoculation, cellular agglomerates on the dermis, 
morphologically compatible with the injected cells were observed in 
60%, 20% and 20% of the animals, respectively. In the later time points, 
these cells were no longer perceived.
Around the clusters it was observed a mild inflammatory infiltrate, 
mainly at 12 hrs, comprising mostly lymphocytes and macrophages 
that decreased along the experiment. At the 7th day of inoculation, a 
central necrosis with macrophages was observed inside the clusters.
Moreover, the histological observation of the organs did not 
reveal any inflammatory, degenerative or necrotic reaction which 
could be associated to the xenotransplanted cells. Local and regional 
Figure 1: Histological image of the skin from control animal. Sample was 
obtained from the correspondent site of the inoculated PBS. Hematoxylin and 
eosin.






Figure 2: Histological images of the clusters present on the dermis and the 
cASCs’ cytoblock. Observe the histology stained with hematoxylin and eosin 
at different times on the column (A). Note that the cASCs cluster is solid at 
12 hrs and progressively necrotic in the centre of the cells. The column (B) 
presented the same tissues on the column (A) immunostained with antibodies 
against large spectrum keratin which did not labeled the cluster. (C) The same 
tissues on the column (A) marked with antibody against vimentin. The positive 
cells are diffused in the cluster with higher density inside. (D) Same tissues as 
in the column (A) to (C) labeled with CD44 antibody. Almost all cells present 
inside the cluster are positive to this marker. 
The cytoblock comprises the same cells inoculated in mice and the 
immunohistochemistry were performed as in the skin. Observe the 
negative stain to keratins and strong positivity to vimentin and CD44. In the 
immunohistochemistry, all slides were counterstained with Gill’s hematoxylin.
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mild inflammatory response and the formation of the cluster of cells [36].
Apart from the subcutaneous injection, other ways of inoculation 
have been reported in different disease models or clinical studies, 
namely, the intraarticular [10,11], the intravenous injection [13] or 
the direct injection into a spinal cord injury [28]. Transplantation of 
cASCs have been described to be carried out by combining them with 
different vehicles such as platelet rich plasma [12], hyaluronic acid [12] 
or PBS [11].
The immunomodulation of the ASCs has been examined in a 
variety of animal models [36]. One of the first in vivo studies on 
systemic infusion of ex-vivo expanded allogenic ASCs dates of 2006, 
when Yanez and colleagues reported that these cells were able to control 
an induced graft-versus-host disease in mice [37]. Human ASCs have 
been shown not to express the MHC-II and did not stimulate allogenic 
peripheral blood mononuclear cells when in co-culture [38]. The 
immunomodulatory potential of the studied cASCs needs to be deeply 
assessed, paving the way for the application of cASCs in medicine 
regenerative approaches not only in the donor patient but also in 
allogenic patients.
The present work also gave a contribution to the study of cASCs 
behavior in a non-autologous host. Envisioning the use of cASCs in 
allogenic therapies, it is important to assess their behavior also in canine 
recipients in the future. Taking into consideration that long-term 
cryopreservation of cASCs did not affect their stem-like features [39], 
it is feasible to create a cell bank of cASCs ready to use in autologous or 
allogenic approaches.
The present study demonstrated, for the first time in our knowledge, 
the presence of cASCs in healthy mice tissue after transplantation. 
Moreover, the obtained data showed the cASCs induced a local mild 
inflammatory reaction in the host. The scarce inflammatory response 
against the cASCs could also be useful to propose this mouse as an 
animal model to study the in vivo behavior of the cASCs and to validate 
cASCs-based therapies avoiding or reducing the use of dogs in research. 
Acknowledgments
The research leading to these results has received funding from the European 
Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement 
n° REGPOT-CT2012-316331-POLARIS and from the Portuguese Foundation 
for Science and Technology (FCT) under the projects MIT/ECE/0047/2009 and 
PEst-OE/AGR/UI0772/2011). J.F. Requicha and P.P. Carvalho acknowledge the 
FCT for their PhD scholarship (SFRH/BD/44143/2008) and Post-Doc scholarship 
(SFRH/BPD/89454/2012), respectively. The authors thank Ligia Lourenço (UTAD) 
for her technical expertise in the histology.
References
1. Friedens AJ, Petrakov KV, Kuroleso AI, Frolova GP (1968) Heterotopic of bone 
marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. 
Transplantation 6: 230-247. [PubMed]
2. Requicha J, Viegas CA, Albuquerque CM, Azevedo JM, Reis RL, et al. (2012) 
Effect of anatomical origin and cell passage number on the stemness and 
osteogenic differentiation potential of canine adipose-derived stem cells. Stem 
Cell Rev Rep 8: 1211-1222. [PubMed]
3. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, et al. (2002) Human 
adipose tissue is a source of multipotent stem cells. Mol Bio Cell 13: 4279-
4295. [PubMed]
4. In 'tAnker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, 
et al. (2003) Amniotic fluid as a novel source of mesenchymal stem cells for 
therapeutic transplantation. Blood 102: 1548-1549. [PubMed]
5. Bieback K, Kern S, Kluter H, Eichler H (2004) Critical parameters for the 
isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22: 
625-634. [PubMed]
6. Requicha JF Viegas CA, Muñoz F, Reis RL, Gomes ME (2013) Periodontal 
As shown in Figures 2A-2D, those cells were positive both to vimentin 
and CD44 and negative to keratins overlapping the cASCs’ cytoblock 
positivity used as control. The intensity was strongest in the cytoblock 
cells then in the skin that shows different intensity for the markers used 
that also varied along the experimental period.
Discussion
The cASCs used in this study were isolated from dog subcutaneous 
tissue by a previously optimized methodology [2]. These cells display 
properties of MSCs namely adherence to culture flasks, positivity to 
the three main characteristic MSCs markers, namely, CD105, CD73 
and CD90, as well as the potential to differentiate into osteogenic 
and chondrogenic lineages [2], fulfilling the minimal criteria for been 
considered MSCs [19].
Although different cell tracking methodologies could have been 
implemented in this study, we were interested in assessing the implanted 
cells in its pure form, as they are envisioned to be used in future clinical 
applications and, therefore without any permeabilization steps or using 
any type of cell surface modification such as fluorochromes, or genetic 
modifications such as transfection. Taking this into consideration we 
decided try to detect cASCs in tissues according to their phenotype, 
through the positive expression of vimentin and CD44, and the 
negative expression of keratins.
Vimentin and keratin are cytoskeleton intermediate filaments. 
MSCs are known to contain vimentin [20] which is involved in 
modulating cell-matrix interactions [21] and it has already been 
detected in cASCs after inducing neurogenic differentiation [22] and 
was highly expressed in MSCs isolated from rodent skin [23].
The antibody against large spectrum keratin used in the present 
work is a combination of acidic and neutral-basic keratins, thus 
covering broad spectra of this protein and, in that sense, minimizing 
the probability of false negatives for keratins' expression on the 
injected cells. In human ASCs committed to the epithelial lineage, 
cytokeratin-18 has been detected, while vimentin reduced its positive 
expression [24].
The CD44 is a membrane glycoprotein and functions as the major 
hyaluronan receptor on most cell types [25], and is one of primary stable 
positive ASCs’ markers [26]. The expression of this marker on cASCs 
has already been shown by Kang (2008) who found immunomodulatory 
behaviour on co-cultured with allogenic leukocyte [27]. Others studies 
on cASCs revealed the positive expression of CD44 by flow cytometry 
and immunocytochemistry [22,28,29], however, in our knowledge, the 
detection of this marker in cASCs after xenotransplantation in an in 
vivo model was not yet been reported.
Several mouse models of disease, such as muscular dystrophy 
[30], colitis [31], rheumatoid arthritis [32], acute kidney injury [33], 
autoimmune hearing loss [34] and systemic lupus erythematosus [35] 
have already been used in the study of the human ASCs behavior and 
therapeutic application.
In this work, it was aimed to assess the response of an 
immunocompetent and healthy model against transplanted cells. This 
absence of disease and chemotactic stimuli in mice could justify that 
no inflammatory reaction was observed in the organs distant from the 
injection site.
The presence of the cASCs in the subcutaneous tissue could be 
related to the physical trauma, induced during the inoculation, which 
could have mimetized a disease model and, thus, promote the only a 
Citation: Requicha JF, de Carvalho PP, dos Anjos Pires M, Dias MI, Reis R, et al. (2016) Evaluation of Canine Adipose-derived Stem Cells in a 
Healthy Mice Subcutaneous Model. J Stem Cell Res Ther 6: 358. doi: 10.4172/2157-7633.1000358
Page 5 of 5
Volume 6 • Issue 9 • 1000358J Stem Cell Res Ther, an open access journalISSN: 2157-7633
tissue engineering strategies based on non-oral stem cells. Anat Rec 297: 
6-15. [PubMed]
7. Seo BM, Miura M, Gronthos S, Bartold PM, Batouli S, et al. (2004) Investigation 
of multipotent postnatal stem cells from human periodontal ligament. Lancet 
364: 149-155. [PubMed]
8. Rada T, Reis RL, Gomes ME (2009) Adipose tissue-derived stem cells and 
their application in bone and cartilage tissue engineering. Tissue Eng Part B 
15: 113-125. [PubMed]
9. Lee HB, Chung YS, Heo SY, Kim NS (2009) Augmentation of bone healing of 
nonunion fracture using stem cell based tissue engineering in a dog: a case 
report. Vet Med-Czech 54: 198-203. 
10. Black LL, Gaynor J, Gahring D, Adams C, Aron D, et al. (2007) Effect of adipose-
derived mesenchymal stem and regenerative cells on lameness in dogs with 
chronic osteoarthritis of the coxofemoral joints: A randomized double-blinded 
multicenter controlled trial. Vet Ther 8: 272-284. [PubMed]
11. Black LL, Gaynor J, Adams C, Dhupa S, Sams AE, et al. (2008) Effect of 
intraarticular injection of autologous adipose-derived mesenchymal stem and 
regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in 
dogs. Vet Ther 9: 192-200. [PubMed]
12. Guercio A, Di Marco P, Casella S, Cannella V, Russotto L, et al. (2012) 
Production of canine mesenchymal stem cells from adipose tissue and their 
application in dogs with chronic osteoarthritis of the humeroradial joints. Cell 
Biol Int 36: 189-194. [PubMed]
13. Hall MN, Rosenkrantz WS, Hong JH, Griffin CE, Mendelsohn CM (2010) 
Evaluation of the potential use of adipose-derived mesenchymal stromal cells 
in the treatment of canine atopic dermatitis: a pilot study. Vet Ther 11: E1-14. 
[PubMed]
14. Ganey T, Hutton WC, Moseley T, Hedrick M, Meisel HJ (2009) Intervertebral 
disc repair using adipose tissue-derived stem and regenerative cells: 
experiments in a canine model. Spine 34: 2297-2304. [PubMed]
15. Hiyama A, Mochida J, Iwashina T, Omi H, Watanabe T, et al. (2008) 
Transplantation of mesenchymal stem cells in a canine disc degeneration 
model. J Orthop Res 26: 589-600. [PubMed]
16. Cui L, Liu B, Liu G, Zhang W, Cen L, et al. (2007) Repair of cranial bone 
defects with adipose derived stem cells and coral scaffold in a canine model. 
Biomaterials 28: 5477-5486. [PubMed]
17. Liu G, Zhang Y, Liu B, Sun J, Li W, et al. (2013) Bone regeneration in a canine 
cranial model using allogeneic adipose derived stem cells and coral scaffold. 
Biomaterials 34: 2655-2664. [PubMed]
18. Seo KW, Lee HW, Oh YI, Ahn JO, Koh YR, et al. (2011) Anti-tumor effects of 
canine adipose tissue-derived mesenchymal stromal cell-based interferon-beta 
gene therapy and cisplatin in a mouse melanoma model. Cytotherapy 13: 944-
955. [PubMed]
19. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) 
Minimal criteria for defining multipotent mesenchymal stromal cells. The 
International Society for Cellular Therapy position statement. Cytotherapy 8: 
315-317. [PubMed]
20. Eriksson JE, Dechat T, Grin B, Helfand B, Mendez M, et al. (2009) Introducing 
intermediate filaments: from discovery to disease. J Clin Invest 119: 1763-
1771. [PubMed]
21. Eckes B, Dogic D, Colucci-Guyon E, Wang N, Maniotis A, et al. (1998) Impaired 
mechanical stability migration and contractile capacity in vimentin-deficient 
fibroblasts. J Cell Sci 111: 1897-1907. [PubMed]
22. Lim JH, Boozer L, Mariani CL, Piedrahita JA, Olby NJ (2010) Generation and 
characterization of neurospheres from canine adipose tissue-derived stromal 
cells. Cell Reprogram 12: 417-425. [PubMed]
23. Toma JG, Akhavan M, Fernandes KJ, Barnabé-Heider F, Sadikot A, et al. 
(2001) Isolation of multipotent adult stem cells from the dermis of mammalian 
skin. Nat Cell Biol 3: 778-784. [PubMed]
24. Brzoska M, Geiger H, Gauer S, Baer P (2005) Epithelial differentiation of human 
adipose tissue-derived adult stem cells. Biochem Biophys Res Commun 330: 
142-150. [PubMed]
25. Thorne RF, Legg JW, Isacke CM (2004) The role of the CD44 transmembrane 
and cytoplasmic domains in co-ordinating adhesive and signalling events. J 
Cell Sci 117: 373-380. [PubMed]
26. Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, et al. (2013) Stromal 
cells from the adipose tissue-derived stromal vascular fraction and culture 
expanded adipose tissue-derived stromal/stem cells: a joint statement of 
the International Federation for Adipose Therapeutics and Science and the 
International Society for Cellular Therapy. Cytotherapy 15: 641-648. [PubMed]
27. Kang JW, Kang KS, Koo HC, Park JR, Choi EW, et al. (2008) Soluble 
factors-mediated immunomodulatory effects of canine adipose tissue-derived 
mesenchymal stem cells. Stem Cells Dev 17: 681-693. [PubMed]
28. Ryu HH, Lim JH, Byeon YE, Park JR, Seo MS, et al. (2009) Functional recovery 
and neural differentiation after transplantation of allogenic adipose-derived 
stem cells in a canine model of acute spinal cord injury. J Vet Sci 10: 273-284. 
[PubMed]
29. Vieira N, Brandalise V, Zucconi E, Secco M, Strauss BE, et al. (2010) Isolation 
characterization and differentiation potential of canine adipose-derived stem 
cells. Cell Transplant 19: 279-289. [PubMed]
30. Rodriguez AM, Pisani D, Dechesne CA, Turc-Carel C, Kurzenne JY, et al. 
(2005) Transplantation of a multipotent cell population from human adipose 
tissue induces dystrophin expression in the immunocompetent mdx mouse. J 
Exp Med 201: 1397-1405. [PubMed]
31. Gonzalez MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M (2009) Adipose-
derived mesenchymal stem cells alleviate experimental colitis by inhibiting 
inflammatory and autoimmune responses. Gastroenterology 136: 978-989. 
[PubMed]
32. Gonzalez MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M (2009) 
Treatment of experimental arthritis by inducing immune tolerance with human 
adipose-derived mesenchymal stem cells. Arthritis Rheum 60: 1006-1019. 
[PubMed]
33. Li K, Han Q, Yan X, Liao L, Zhao RC (2010) Not a process of simple 
vicariousness the differentiation of human adipose-derived mesenchymal stem 
cells to renal tubular epithelial cells plays an important role in acute kidney 
injury repairing. Stem Cells Dev 19: 1267-1275. [PubMed]
34. Zhou Y, Yuan J, Zhou B, Lee AJ, Lee AJ, et al. (2011) The therapeutic efficacy 
of human adipose tissue-derived mesenchymal stem cells on experimental 
autoimmune hearing loss in mice. Immunology 133: 133-140. [PubMed]
35. Choi EW, Shin IS, Park SY, Park JH, Kim JS, et al. (2012) Reversal of 
serologic immunologic and histologic dysfunction in mice with systemic lupus 
erythematosus by long-term serial adipose tissue-derived mesenchymal stem 
cell transplantation. Arthritis Rheum 64: 243-253. [PubMed]
36. Lin CS, Lin GT, Lue TF (2012) Allogeneic and xenogeneic transplantation 
of adipose-derived stem cells in immunocompetent recipients without 
immunosuppressants. Stem Cells Dev 21: 2770-2778. [PubMed]
37. Yanez R, Lamana ML, García-Castro J, Colmenero I, Ramírez M, et 
al. (2006) Adipose tissue-derived mesenchymal stem cells have in vivo 
immunosuppressive properties applicable for the control of the graft-versus-
host disease. Stem Cells 24: 2582-2591. [PubMed]
38. Niemeyer P, Kornacker M, Mehlhorn A, Seckinger A, Vohrer J, et al. (2007) 
Comparison of immunological properties of bone marrow stromal cells and 
adipose tissue-derived stem cells before and after osteogenic differentiation in 
vitro. Tissue Eng 13: 111-121. [PubMed]
39. Martinello T, Bronzini I, Maccatrozzo L, Mollo A, Sampaolesi M, et al. (2011) 
Canine adipose-derived-mesenchymal stem cells do not lose stem features 
after a long-term cryopreservation. Res Vet Sci 91: 18-24. [PubMed]
Citation: Requicha JF, de Carvalho PP, dos Anjos Pires M, Dias MI, Reis R, 
et al. (2016) Evaluation of Canine Adipose-derived Stem Cells in a Healthy 
Mice Subcutaneous Model. J Stem Cell Res Ther 6: 358. doi: 10.4172/2157-
7633.1000358
